ARE
Alexandria Real Estate Equities, Inc.
REIT - Office
Market Cap$7.89B
5Y Perf.-75.9%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
ARE vs ONCO
Revenue, margins, valuation, and 5-year total return — side by side.
ONCO
Onconetix, Inc.
Biotechnology
Market Cap$1M
5Y Perf.-100.0%
ARE vs ONCO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ARE | ONCO |
|---|---|---|
| Industry | REIT - Office | Biotechnology |
| Market Cap | $7.89B | $1M |
| Revenue (TTM) | $2.90B | $815K |
| Net Income (TTM) | $-1.02B | $-14M |
| Gross Margin | 68.2% | 77.6% |
| Operating Margin | -42.8% | -21.9% |
| Forward P/E | 78.8x | — |
| Total Debt | $12.76B | $49K |
| Cash & Equiv. | $549M | $5M |
ARE vs ONCO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
ARE
ONCO
| Stock | Feb 22 | May 26 | Return |
|---|---|---|---|
| Alexandria Real Est… (ARE) | 100 | 24.1 | -75.9% |
| Onconetix, Inc. (ONCO) | 100 | 0.0 | -100.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ARE vs ONCO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: ARE leads in 6 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ARE
Alexandria Real Estate Equities, Inc.
The Real Estate Income Play
ARE carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 15 yrs, beta 0.95, yield 11.7%
- Rev growth -2.6%, EPS growth -5.7%, 3Y rev CAGR 4.9%
- -8.6% 10Y total return vs ONCO's -100.0%
Best for: income & stability and growth exposure
ONCO
Onconetix, Inc.
The Defensive Pick
ONCO is the clearest fit if your priority is defensive.
- Beta 1.41, yield 30.9%, current ratio 0.66x
Best for: defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | ARE | -2.6% FFO/revenue growth vs ONCO's -67.7% |
| Quality / Margins | ARE | -35.3% margin vs ONCO's -17.2% |
| Stability / Safety | ARE | Beta 0.95 vs ONCO's 1.41 |
| Dividends | ARE | 11.7% yield, 15-year raise streak, vs ONCO's 30.9% |
| Momentum (1Y) | ARE | -30.9% vs ONCO's -98.6% |
| Efficiency (ROA) | ARE | -2.9% ROA vs ONCO's -68.0%, ROIC -2.7% vs -32.8% |
ARE vs ONCO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
ARE vs ONCO — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLARELAGGINGONCO
ONCOOnconetix, Inc.
1leads
AREAlexandria Real Estat…
4leads
6 Total Categories
CATEGORYLEADERvs ONCOMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
ARE5/6
Valuation MetricsMultiples, price ratios, and targets
ONCO2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ARE5/8
Total Returns1Y, 3Y, 5Y total returns with dividends
ARE6/6
Risk & VolatilityBeta, volatility, and downside exposure
ARE2/2
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
ARE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARE is the larger business by revenue, generating $2.9B annually — 3554.9x ONCO's $815,371. Profitability is closely matched — net margins range from -35.3% (ARE) to -17.2% (ONCO). On growth, ARE holds the edge at -9.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | AREAlexandria Real E… | ONCOOnconetix, Inc. |
|---|---|---|
| RevenueTrailing 12 months | $2.9B | $815,371 |
| EBITDAEarnings before interest/tax | $74M | -$18M |
| Net IncomeAfter-tax profit | -$1.0B | -$14M |
| Free Cash FlowCash after capex | $1.4B | -$10M |
| Gross MarginGross profit ÷ Revenue | +68.2% | +77.6% |
| Operating MarginEBIT ÷ Revenue | -42.8% | -21.9% |
| Net MarginNet income ÷ Revenue | -35.3% | -17.2% |
| FCF MarginFCF ÷ Revenue | +48.4% | -11.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -9.7% | -57.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +31.9% | +120.9% |
ARE leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
ONCO leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | AREAlexandria Real E… | ONCOOnconetix, Inc. |
|---|---|---|
| Market CapShares × price | $7.9B | $1M |
| Enterprise ValueMkt cap + debt − cash | $20.1B | -$4M |
| Trailing P/EPrice ÷ TTM EPS | -5.40x | -0.09x |
| Forward P/EPrice ÷ next-FY EPS est. | 78.79x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 135.65x | — |
| Price / SalesMarket cap ÷ Revenue | 2.66x | 1.70x |
| Price / BookPrice ÷ Book value/share | 0.41x | 0.08x |
| Price / FCFMarket cap ÷ FCF | 5.58x | — |
ONCO leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
ARE leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
ARE delivers a -5.0% return on equity — every $100 of shareholder capital generates $-5 in annual profit, vs $-190 for ONCO. ONCO carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARE's 0.67x.
| Metric | AREAlexandria Real E… | ONCOOnconetix, Inc. |
|---|---|---|
| ROE (TTM)Return on equity | -5.0% | -189.8% |
| ROA (TTM)Return on assets | -2.9% | -68.0% |
| ROICReturn on invested capital | -2.7% | -32.8% |
| ROCEReturn on capital employed | -3.6% | -49.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.67x | 0.00x |
| Net DebtTotal debt minus cash | $12.2B | -$5M |
| Cash & Equiv.Liquid assets | $549M | $5M |
| Total DebtShort + long-term debt | $12.8B | $48,774 |
| Interest CoverageEBIT ÷ Interest expense | -4.37x | -26.95x |
ARE leads this category, winning 5 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
ARE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARE five years ago would be worth $3,887 today (with dividends reinvested), compared to $0 for ONCO. Over the past 12 months, ARE leads with a -30.9% total return vs ONCO's -98.6%. The 3-year compound annual growth rate (CAGR) favors ARE at -21.2% vs ONCO's -97.2% — a key indicator of consistent wealth creation.
| Metric | AREAlexandria Real E… | ONCOOnconetix, Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -5.5% | -95.0% |
| 1-Year ReturnPast 12 months | -30.9% | -98.6% |
| 3-Year ReturnCumulative with dividends | -51.0% | -100.0% |
| 5-Year ReturnCumulative with dividends | -61.1% | -100.0% |
| 10-Year ReturnCumulative with dividends | -8.6% | -100.0% |
| CAGR (3Y)Annualised 3-year return | -21.2% | -97.2% |
ARE leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
ARE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ARE is the less volatile stock with a 0.95 beta — it tends to amplify market swings less than ONCO's 1.41 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ARE currently trades 51.7% from its 52-week high vs ONCO's 0.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | AREAlexandria Real E… | ONCOOnconetix, Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.95x | 1.41x |
| 52-Week HighHighest price in past year | $88.24 | $74.30 |
| 52-Week LowLowest price in past year | $39.41 | $0.37 |
| % of 52W HighCurrent price vs 52-week peak | +51.7% | +0.5% |
| RSI (14)Momentum oscillator 0–100 | 52.2 | 28.8 |
| Avg Volume (50D)Average daily shares traded | 2.5M | 9.4M |
ARE leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Evenly matched — ARE and ONCO each lead in 1 of 2 comparable metrics.
Analyst Outlook
For income investors, ONCO offers the higher dividend yield at 30.89% vs ARE's 11.74%.
| Metric | AREAlexandria Real E… | ONCOOnconetix, Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — |
| Price TargetConsensus 12-month target | $55.00 | — |
| # AnalystsCovering analysts | 24 | — |
| Dividend YieldAnnual dividend ÷ price | +11.7% | +30.9% |
| Dividend StreakConsecutive years of raises | 15 | 0 |
| Dividend / ShareAnnual DPS | $5.35 | $0.12 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.6% | 0.0% |
Evenly matched — ARE and ONCO each lead in 1 of 2 comparable metrics.
Key Takeaway
ARE leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ONCO leads in 1 (Valuation Metrics). 1 tied.
Best OverallAlexandria Real Estate Equi… (ARE)Leads 4 of 6 categories
Loading custom metrics...
ARE vs ONCO: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is ARE or ONCO a better buy right now?
For growth investors, Alexandria Real Estate Equities, Inc.
(ARE) is the stronger pick with -2. 6% revenue growth year-over-year, versus -67. 7% for Onconetix, Inc. (ONCO). Analysts rate Alexandria Real Estate Equities, Inc. (ARE) a "Hold" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ARE or ONCO?
Over the past 5 years, Alexandria Real Estate Equities, Inc.
(ARE) delivered a total return of -61. 1%, compared to -100. 0% for Onconetix, Inc. (ONCO). Over 10 years, the gap is even starker: ARE returned -8. 6% versus ONCO's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ARE or ONCO?
By beta (market sensitivity over 5 years), Alexandria Real Estate Equities, Inc.
(ARE) is the lower-risk stock at 0. 95β versus Onconetix, Inc. 's 1. 41β — meaning ONCO is approximately 49% more volatile than ARE relative to the S&P 500. On balance sheet safety, Onconetix, Inc. (ONCO) carries a lower debt/equity ratio of 0% versus 67% for Alexandria Real Estate Equities, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — ARE or ONCO?
By revenue growth (latest reported year), Alexandria Real Estate Equities, Inc.
(ARE) is pulling ahead at -2. 6% versus -67. 7% for Onconetix, Inc. (ONCO). On earnings-per-share growth, the picture is similar: Onconetix, Inc. grew EPS 99. 1% year-over-year, compared to -568. 9% for Alexandria Real Estate Equities, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ARE or ONCO?
Alexandria Real Estate Equities, Inc.
(ARE) is the more profitable company, earning -48. 2% net margin versus -1721. 0% for Onconetix, Inc. — meaning it keeps -48. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ARE leads at -40. 5% versus -778. 2% for ONCO. At the gross margin level — before operating expenses — ONCO leads at 77. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — ARE or ONCO?
All stocks in this comparison pay dividends.
Onconetix, Inc. (ONCO) offers the highest yield at 30. 9%, versus 11. 7% for Alexandria Real Estate Equities, Inc. (ARE).
07Is ARE or ONCO better for a retirement portfolio?
For long-horizon retirement investors, Alexandria Real Estate Equities, Inc.
(ARE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 95), 11. 7% yield). Both have compounded well over 10 years (ARE: -8. 6%, ONCO: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between ARE and ONCO?
These companies operate in different sectors (ARE (Real Estate) and ONCO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(ARE: -9.7% · ONCO: -57.4%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.